Black Owned Bio Tech Firm is Gearing Up for a Racially Charged Trial Against Kaiser Permanente

Black Owned Bio Tech Firm is Gearing Up for a Racially Charged Trial Against Kaiser Permanente

August 2, 2021

Nationwide — ViQUAL Medical Technology LLC, a small Black-owned biotech firm based in San Diego, is gearing up for its upcoming trial against Kaiser Permanente in a trade secret misappropriation case by taking on new legal representation. This action follows ViQUAL Medical Technology’s favorable ruling late last year granting their attorney’s Motion to Compel against Kaiser Permanente a large healthcare behemoth. The Court recently set this case for trial on November 5, 2021.

ViQUAL Medical was created to be a medical device division of Better Life Technologies Group, Inc., which received intellectual property from Better Life Technologies Group, Inc., and subsequently created its own unique patent-pending and trade secreted technologies. The trade secrets involved, “a technology designed to help monitor patients suffering from diabetes, heart conditions, cancer and a host of other medical diseases in an encrypted manner that complied with HIPPA regulations” which was a completely novel concept in 2012. ViQUAL officials and founders, George McKinney and Keith Mathis assert that their patent-pending technologies also have been integrated into the healthcare application of IOT (Internet of Things). Further, ViQUAL asserts that because of Kaiser’s breach of contract they are deprived of hundreds of millions of dollars in revenues.

Read the source article at BlackNews.com

© Copyright 2024, All Rights Reserved | National Black Lawyers
crossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram